BeingWell
Published in

BeingWell

Pfizer COVID-19 Pill 89% Effective in Reducing Hospitalization and Death

If the FDA grants emergency use authorization for the drug, it could become available in the U.S. by next year

Pfizer has been conducting a randomized, double-blind study of their antiviral pill to a cohort of 1,881 non-hospitalized adult patients with COVID-19. They…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Dr. Zach Zachariah

Ph.D. chemist with an M.B.A. | Enrolled Agent | Writes on science | economy | taxes | public interest topics | American politics | Indian-Americans | COVID-19